MedPath

A CLINICAL TRAIL TO STUDY THE EFFECT OFTWO DRUGS TIMIRGHNATRIFLAM GHRUTA AND TRIPHALADI GHRUTA ORAL ADMINISTRATION IN PATIENTS WITH MYOPIA

Phase 2
Conditions
Health Condition 1: - Health Condition 2: H578- Other specified disorders of eye and adnexaHealth Condition 3: H578- Other specified disorders of eye and adnexaHealth Condition 4: H578- Other specified disorders of eye and adnexaHealth Condition 5: H578- Other specified disorders of eye and adnexa
Registration Number
CTRI/2023/04/051229
Lead Sponsor
mahatma gandhi ayurved college hospial and research center
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

patient of age group 10 to 30 years with refreactive error myopia upto -2.75D

[

Exclusion Criteria

patient having major ocular disease like corneal opacity cataract etc.

patient having any other known ocular retinal pathology, squint, amblyopia etc

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
PARAMETER ARE VIHWALA DARSHANA ,NETRAYASA,SHIROBHITAPA,DURASHTA AVYAKTA DARSHAN ,AUTO REFRACTIVEMETER SNELLENS CHART,FUNDUS VEXAMINATIONTimepoint: 14 DAY,28 DAY,AFTER 6 MONTH
Secondary Outcome Measures
NameTimeMethod
refreactive index wil be improvement upto -1D assisment will be done for the patient having UPTO -2.75 DTimepoint: refreactive index can be IMPROVEMENT to its possible extent28 days to 6 month
© Copyright 2025. All Rights Reserved by MedPath